As of 2013, about 1.2 billion people are categorized as extremely poor and are living on less than US$1.25 a day. Combined with those who live on less than US$2 a day, 2.4 billion people live in poverty, or about one-third of the world’s population. Many of these people suffer from illnesses but are unable to receive proper medical care or the medicines they need.
Bonnie Gillespie, Courtesy of Photoshare
The issue of access to medicines is that proper medicines and medical treatments are unavailable to patients in need for reasons of poverty, underdeveloped healthcare systems or other factors, particularly in the context of high-growth emerging countries and the developing world.
Medical and pharmaceutical products have played an important role in the attempt to achieve global health (see Study Note below), which aims to improve health standards and reduce health disparities on a global level. To ensure that medicines are made available to all patients in need, a mechanism is required for the smooth distribution of high-quality, safe pharmaceutical products and for the promotion of their effective use. It is also extremely important to establish basic infrastructure such as medical facilities and insurance systems. In order to improve access to medical and pharmaceutical products, it is necessary to promote the drug affordability and availability, adoption, and support for medical infrastructure. Achieving these priorities necessitates a collaborative approach among governments, the private sector, and the academic community (see chart below).
To improve access to medical and pharmaceutical products, it is essential to promote the affordability of these products, their availability, and their appropriate use by patients as well as to improve the medical infrastructure that facilitates that promotion.
Source : Laura J. Frost & Michael R. Reich, Access, Harvard Center for Population and Development Studies, 2008.
To make medicines and medical treatment affordable and in line with a country’s social system, economy, and medical environment
To make medicines and medical treatment available by opening hospitals and pharmacies in local neighborhoods as well as by granting licenses to market medical products in every community
To have patients accurately recognize treatment benefits and to encourage them to consciously adopt the use of these medicines
To establish a strategy and mechanism to accomplish the above three A’s, including the medical infrastructure, such as health insurance systems, as well as education systems to develop medical professionals
It would be difficult for any company or a country to solve the issue of access to medicines alone. Recognizing this, access to medicines has been continually addressed through partnerships among governments, pharmaceutical manufacturers, international organizations and nonprofit organizations (NPOs). The following “three D’s” are important for promoting these partnerships.
To research treatments and medicines for diseases prevalent in developing countries in cases where an effective treatment has not yet been discovered, so as to identify potential drug seeds
To develop and receive approval for the practical application of newly discovered medicines and diagnostics
To deliver developed medicines and diagnostics to market and promote their use through education for patients and medical professionals
This is an attempt to explore health and medical problems and their solutions on a global scale. It aims to reduce the health gap among countries, including both developing and developed nations. While “global health” covers a wide range of issues, the following are the most significant:
In developing countries, mortality rates for pregnant women and infants remain extremely high due to poverty and weak health and/or medical systems, posing a major social problem. One issue that demands an urgent solution is the cause of short average life expectancies in developing countries. The Millennium Development Goals (MDGs), set out in 2000 as goals for the international community in the 21st century, include reducing the mortality rates of infants and pregnant women.
According to The State of Food Insecurity in the World 2012 compiled by the Food and Agriculture Organization of the United Nations (FAO), in 2008 one out of eight people suffered from chronic malnutrition. The vast majority of these people live in developing countries, and malnutrition continues to grow in sub-Saharan Africa even today. Malnutrition has been a major cause of over 100 million children under five years being underweight, with some 2.5 million of that number dying prematurely every year. The MDG for malnutrition is to reduce the percentage of the population suffering from hunger to 50% of the 1990 figure by 2015.
One issue of the utmost urgency is the control of the Three Major Infectious Diseases: HIV/AIDS, malaria, and tuberculosis. Statistics show that 3.5 million people worldwide (as of 2012) die from one of these three diseases every year. This creates an epidemic in many developing countries where people do not receive proper medicines or medical care due to poverty, resulting in these diseases spreading further. The MDG in this area is to arrest the spread of these diseases by 2015 and consequently reduce the number of the infected population.
In many developing and emerging countries, health/medical insurance systems are underdeveloped. Even in countries where health insurance systems are advanced, the number of subscribers remains small compared with industrialized countries, and the coverage of these systems is still very limited. For these reasons, the ratio of patient’s co-pay for the cost of health care in those countries remain high, resulting in a great number of people who do not receive medical treatment. Also, the gap between cities and rural areas in terms of medical facilities and medical services is a serious social problem (see chart below). Improved access to medical treatment and medicines is another pressing global issue.
A health care system is how a state provides its people with medical treatments and healthcare services. The chart below summarizes the targets of some nations for their healthcare security system, measures to aide people with low incomes meet their healthcare needs, and health/medical issues in their respective countries.
Target of the health care system | Insurance system targeting those with low incomes | Other health/medical issues | |
---|---|---|---|
|
|
|
|
![]() |
|
|
|
![]() |
|
|
|
![]() |
|
|
|
![]() |
|
|
|
A health care system is how a state provides its people with medical treatments. The chart below summarizes several nations’ targets for their medical security systems, measures for aiding people with low incomes, and health/medical issues.
In addition to the three major infectious diseases : Malaria, HIV/AIDS, tuberculosis (see Study Note above), a large number of other diseases have created social problems in many developing and emerging countries. Of these diseases, the most prominent are the neglected tropical diseases (NTDs) in terms of economic loss.
NTDs are epidemic in 149 countries and territories around the world, with some 1 billion people currently infected with an NTD. The economic impact from these diseases has been enormous. For instance, blinding trachoma has cost more than US$2 billion, lymphatic filariasis more than US$1 billion, and Chagas’ disease more than US$1 billion each year.
Poverty is a major factor behind epidemics of NTDs. In fact, when an NTD becomes epidemic due to poverty, the increase in the number of people with infectious diseases leads to further poverty, thus creating a negative spiral. Many people become incapacitated because of the symptoms of the diseases or their after-effects; in serious cases, they result in death. This in turn leads to a decline in the country’s work force and productivity. Improving access to medicines and taking effective measures against these diseases therefore lead to the long-term alleviation of poverty as well as to economic growth (see chart below).